13FPulse
AB

ABUS ARBUTUS BIOPHARMA CORP

2026Q2 · CUSIP 03879J100 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
174
Institutions that reported holding it to the SEC
Net increase in holders
+9
Last quarter 165 → now 174
How unusual is that
Above average
Stronger buying than 67% of US stocks
What the filings say, in one paragraph

174 funds held ABUS at the end of 2026Q2, up 9 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $182M(YoY +1078.8%), the P/E is 6.4x, return on equity is 59.2%. ABUS has had 8 buying rushes in its history, and the price moved -24.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2015Q3: holders=55 2015Q4: holders=51 2016Q1: holders=50 2016Q2: holders=52 2016Q3: holders=48 2016Q4: holders=56 2017Q1: holders=53 2017Q2: holders=50 2017Q3: holders=53 2017Q4: holders=50 2018Q1: holders=49 2018Q2: holders=69 2018Q3: holders=86 2018Q4: holders=69 2019Q1: holders=69 2019Q2: holders=60 2019Q3: holders=53 2019Q4: holders=57 2020Q1: holders=47 2020Q2: holders=50 2020Q3: holders=64 2020Q4: holders=80 2021Q1: holders=94 2021Q2: holders=91 2021Q3: holders=98 2021Q4: holders=123 2022Q1: holders=116 2022Q2: holders=112 2022Q3: holders=125 2022Q4: holders=113 2023Q1: holders=121 2023Q2: holders=110 2023Q3: holders=98 2023Q4: holders=111 2024Q1: holders=118 2024Q2: holders=131 2024Q3: holders=144 2024Q4: holders=153 2025Q1: holders=167 2025Q2: holders=161 2025Q3: holders=167 2025Q4: holders=171 2026Q1: holders=165 2026Q2: holders=174 -54 -27 +0 +27 +54 42113183 15Q316Q418Q119Q220Q321Q423Q124Q225Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 8 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q1 Top 20% +11.5% +45.0%
2023Q1 Top 20% -17.9% -27.0%
2022Q3 Top 20%
2021Q4 Top 20% -27.4% -24.5%
2020Q3 Top 20%
2018Q3 Top 20% -20.4% -55.6%
2018Q2 Top 20% -51.9% -58.6%
2015Q3 Top 1% in the market -42.5% -26.9%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
104
Change in large funds
+12
Total value they hold
$666M
Funds buying for the first time
34
Funds that sold out entirely
25
Price change that quarter
+21.6%
Funds holding puts (bearish)
2
Funds holding calls (bullish)
2

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
6.4
EPS (TTM)
$0.79
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+1078.8%
Net margin
84.2%
ROE
59.2%
Debt ratio
5.6%
FCF (TTM)
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.24 2021-12-31: EPS -0.15 2022-03-31: EPS -0.11 2022-06-30: EPS -0.10 2022-09-30: EPS -0.12 2022-12-31: EPS -0.13 2023-03-31: EPS -0.10 2023-06-30: EPS -0.10 2023-09-30: EPS -0.12 2023-12-31: EPS -0.12 2024-03-31: EPS -0.10 2024-06-30: EPS -0.11 2024-09-30: EPS -0.10 2024-12-31: EPS -0.07 2025-03-31: EPS -0.13 2025-06-30: EPS 0.01 2025-09-30: EPS -0.04 2025-12-31: EPS -0.01 2026-03-31: EPS 0.87 2026-06-30: EPS -0.03 0M 90M 179M $M -0.26 0.35 0.96 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
5 5 6 2026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-27M-3M21M 20162017201820192020202120222023202420252026
Latest quarter $-5M (2025-12-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.